Glenmark Life Sciences Limited: IPO Review
Glenmark Life Sciences Limited incorporated is a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited (“Glenmark”), a research-oriented, innovation led, global pharmaceutical company, spun off as part of a broader reorganization. It is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system
Glenmark Life Sciences Limited: IPO Review Read More »

